illumina stock downgraded

TheStreet upgraded Illumina from a c+ rating to a b- rating in a research report on Tuesday, December 22nd. From January 11 to January 25 the shares have gained in 10 out of the last 15 years. Get Free Updates. The shares were sold at an average price of $315.32, for a total value of $397,303.20. The firm’s revenue for the quarter was down 12.5% compared to the same quarter last year. It is not often that stocks manage to gain so many days in a row, and falls for … Seasonally this is a strong time of year for Illumina. They now have a $285.00 price target on the stock… Zacks Investment Research Downgrades Illumina (NASDAQ:ILMN) to Sell. Companies can get downgraded for a number of reasons but primarily due to reduced future earnings potential due to loss of contracts, faultering product lines, â¦ ILMN has been the topic of several other research reports. Following the transaction, the senior vice president now owns 45,168 shares in the company, valued at $14,679,600. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. November 6, 2018 Brian Donovan. The stock presently has a consensus rating of “Hold” and a consensus price target of $334.14. Keith Speights (TMFFishBiz) Sep 21, 2020 at 12:15PM Author Bio. Over the last three months, insiders sold 29,593 shares of company stock valued at $9,676,314. Finally, Argus reduced their price objective on Illumina from $380.00 to $355.00 in a research report on Tuesday, December 1st. The final trade Wednesday hit the tape at $26.90. William Blair decreased the Stock from a âOutperformâ to a âMkt Performâ.. Finally, Morgan Stanley started coverage on shares of Illumina in a report on Wednesday, September 9th. Illumina Stock Downgraded to 'In-Line' by Evercore ISI. The business had revenue of $794.00 million during the quarter, compared to analysts’ expectations of $713.97 million. Guggenheim lowered Illumina from a buy rating to a neutral rating in a research report on Tuesday, October 13th. In other Illumina news, Director Jay T. Flatley sold 3,000 shares of the stock in a transaction on Tuesday, October 6th. Also, SVP Susan H. Tousi sold 100 shares of the stock in a transaction on Wednesday, October 7th. In the third quarter, Illumina showed an EPS of $1.02, compared to $1.93 from the year-ago quarter. A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Market Watch . The sale was disclosed in a filing with the SEC, which is available through the SEC website. ... Illumina stock price target cut to $280 from $390 at J.P. Morgan MarketWatch. 07/12/2019 Illumina, Inc. (NASDAQ: ILMN) was downgraded by analysts at Bank of America Corp from a "buy" rating to an "underperform" rating. Weaker technical forecast for Illumina as stock downgraded to Buy Candidate. UBS Group downgraded Illumina from a “buy” rating to a “neutral” rating and decreased their price objective for the company from $390.00 to $285.00 in a report on Tuesday, September 22nd. Zacks Investment Research downgraded shares of Illumina from a buy rating to a hold rating in a â¦ Subscribe. Buckley Wealth Management LLC’s holdings in Illumina were worth $814,000 as of its […] MarketWatch. Posted by Clark Linder on Dec 3rd, 2020. ET by MarketWatch Automation PerkinElmer Inc. stock falls Wednesday, underperforms market Shares of ILMN opened at $364.09 on Thursday. Downgraded Stocks on NYSE, NASDAQ, AMEX, TSE, and TSX. Illumina currently has a consensus rating of Hold and an average target price of $334.14. They issued an “equal weight” rating and a $400.00 price target for the company. Mercer Global Advisors Inc. ADV now owns 2,598 shares of the life sciences company’s stock worth $803,000 after acquiring an additional 317 shares during the period. Illumina (ILMN) cut its third-quarter revenue forecast and was downgraded by Citi and Janney Capital. Shares of NASDAQ:ILMN traded up $6.48 during midday trading on Wednesday, reaching $340.82. Realize the Full Potential of the NextSeq 2000 with the Power of the P3 Reagent Kit BusinessWire - BZX. Exane Derivatives increased its stake in shares of Illumina by 2.3% in the 3rd quarter. Bank Bradesco (BBD:NYS) and Illumina (ILMN:NAS) Downgraded. Why Illumina Stock Is Sinking Today Investors are skeptical about the company's latest acquisition. S&P 500 3,798.91. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. Illumina’s revenue for the quarter was down 12.5% compared to the same quarter last year. Buckley Wealth Management LLC grew its stake in shares of Illumina, Inc. (NASDAQ:ILMN) by 11.7% in the 4th quarter, Holdings Channel reports. Illumina, Inc. (NASDAQ: ILMN) announced Monday a deal to buy privately held Grail, which focuses on early detection of multiple cancers, for $8 billion in cash and stock. The Illumina â¦ The disclosure for this sale can be found here. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. Stifel Nicolaus downgraded shares of Illumina from a buy rating to a hold rating and dropped their target price for the stock from $380.00 to $280.00 in a research report on Tuesday, September 22nd. Several other research analysts have also recently issued reports on the company. Zacks. Illumina, Inc. (ILMN): Downgrade News. GenMark Diagnostics Downgraded by JP Morgan to Neutral. The stock was sold at an average price of $317.79, for a total transaction of $953,370.00. There has … Illumina, Inc. (NASDAQ: ILMN) announced Monday a deal to buy privately held Grail, which focuses on early detection of multiple cancers, for $8 billion in cash and stock. Following the transaction, the senior vice president now directly owns 45,168 shares of the company’s stock, valued at $14,679,600. Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. (Updated - September 22, 2020 4:27 AM EDT) Stifel analyst Daniel Arias downgraded Illumina (NASDAQ: ILMN) from Buy to Hold with a price target of $280.00 (from … Scott & Selber Inc. boosted its position in shares of Illumina by 0.5% during the 3rd quarter. There has â¦ Appleton Partners Inc. MA lifted its holdings in Illumina by 0.5% in the 2nd quarter. Illumina shares declined 26.87 percent to $135.18 in pre-market trading. The company has a current ratio of 3.88, a quick ratio of 3.51 and a debt-to-equity ratio of 0.14. in a research report on Friday, August 7th. Several large investors have recently bought and sold shares of the company. Illumina Stock Downgraded to 'In-Line' by Evercore ISI. Pressure associated with competition and reimbursement may erode GenMark's market share and product pricing, JP Morgan said. Downgrades. JPMorgan Chase & Co. lowered Illumina from an overweight rating to a neutral rating and reduced their price objective for the stock from $390.00 to $280.00 in a research report on Monday, September 21st. Illumina, Inc. (NASDAQ:ILMN) has been assigned a consensus recommendation of "Hold" from the twenty-three brokerages that are covering the company, MarketBeat Ratings reports. Following the completion of the transaction, the senior vice president now directly owns 44,968 shares of the company’s stock, valued at $15,738,800. Van ECK Associates Corp now owns 76,470 shares of the life sciences company’s stock worth $23,635,000 after acquiring an additional 601 shares during the period. Keith began writing for â¦ Roche offered to buy Illumina for $5.7 billion in January and later raised its offer to $51 per share, or $6.5 billion. The firm has a fifty day moving average price of $333.91 and a 200-day moving average price of $342.27. 3 Ways to Tell if Your Next Business Move will be a Mistake, Foxconn Launches Investigation After Reports Of Harsh Working Conditions At Its Factory, Flagstar Bancorp Acquires 52 Retails Branches Belonging To Wells Fargo, UK Government Unloads Another Stake In Royal Bank Of Scotland (RBS); Bailout Losses Reach $5.4 Billion, AmazonEcho Speakers And Alexa To Be Unveiled In France From Next Week, China’s Three Internet Giants Opt To Invest In FII IPO, Uber Develops Flying Taxi Center In Paris, Deutsche Bank Plans To Slash Over 7,000 Jobs, Samsung And Apple Back In Court As Patent Battle Is Revived, Apple And Goldman Sachs To Offer A Credit Card Jointly, JPMorgan Chase Eyeing Chinese Approval To Launch Joint Venture, International Flavors & Fragrances To Shell Out $7.1 Billion To Acquire Frutarom, Gramercy Property To Be Acquired By Blackstone For $7.6 Billion, Boeing To Spend $3.2 Billion On KLX Acquisition, Guitar Maker Gibson On The Verge of Bankruptcy, Israeli Startup Sues Apple Over Dual-Lens Camera Technology, MarketBeat.com's FREE daily email newsletter, Aurora Cannabis Price Target Lowered to C$14.00 at CIBC. Scott & Selber Inc. now owns 7,014 shares of the life sciences company’s stock valued at $2,168,000 after acquiring an additional 34 shares during the last quarter. Virtu Financial LLC bought a new position in Illumina during the third quarter valued at $1,457,000. 78.43% of the stock is owned by institutional investors and hedge funds. GenMark Diagnostics Downgraded by JP Morgan to Neutral. 06:14AM : Is Illumina Making an $8 Billion Blunder? Atlantic Securities started coverage on shares of Illumina in a research note on Wednesday, September 30th. Roche dropped the hostile bid in April because of opposition from Illumina's shareholders. Buckley Wealth Management LLCâs holdings in Illumina were worth $814,000 as of its [â¦] , and has now gained 7 days in a row. Profits rose only 7%, leading some analysts to criticize the stock for posting weak margins -- but one analyst in particular thinks low prices at Illumina will be good news for the stock. Illumina had a return on equity of 15.93% and a net margin of 19.70%. Illumina (NASDAQ:ILMN) last released its quarterly earnings results on Thursday, October 29th. 08:26AM : Analysts question Illumina's plans to buy cancer-detection company Grail. ... Illumina has 5500 employees and is headquartered in United States. Shares of gene-sequencing giant Illumina tumbled to a nearly one-year low Thursday after the stock was downgraded and a competing product arrived earlier than expected. 0.38% of the stock is currently owned by company insiders. SHARE ACTION: Illumina stock lost $1.56, or 3 percent, to $51.37 in afternoon trading. Jul. Zacks: Brokerages Anticipate Facebook, Inc. (NASDAQ:FB) Will Announce Earnings of $3.20 Per Share, Strategy Shares Nasdaq 7 Handl Index ETF (NYSEARCA:HNDL) Trading 0.1% Higher, MarketBeat.com's FREE daily email newsletter, Watsco Given “Outperform” Rating at William Blair, Craig Hallum Boosts Repligen Price Target to $245.00, Halliburton Price Target Raised to $20.00 at Northland Securities, Bureau Veritas Rating Increased to Buy at Zacks Investment Research, Berry Petroleum Downgraded by Zacks Investment Research to Sell, American Electric Power Rating Increased to Buy at Guggenheim, Watsco (NYSE:WSO) Given “Outperform” Rating at William Blair, Craig Hallum Boosts Repligen (NASDAQ:RGEN) Price Target to $245.00, Halliburton (NYSE:HAL) Price Target Raised to $20.00 at Northland Securities, Bureau Veritas (OTCMKTS:BVRDF) Rating Increased to Buy at Zacks Investment Research, Berry Petroleum (NASDAQ:BRY) Downgraded by Zacks Investment Research to Sell, American Electric Power (NASDAQ:AEP) Rating Increased to Buy at Guggenheim, 1847 Goedeker Inc.’s Lock-Up Period To Expire on January 27th (NYSE:GOED), MSCI Inc. Forecasted to Earn FY2020 Earnings of $7.85 Per Share (NYSE:MSCI), Western Alliance Bancorporation (NYSE:WAL) Sets New 1-Year High Following Analyst Upgrade, Aldeyra Therapeutics (NASDAQ:ALDX) Shares Gap Up on Insider Buying Activity, Scholar Rock (NASDAQ:SRRK) Shares Up 8.2% on Analyst Upgrade, Upstart Holdings, Inc.’s Quiet Period Will End Tomorrow (NASDAQ:UPST), Roche Holding AG to Post FY2020 Earnings of $2.68 Per Share, Jefferies Financial Group Forecasts (OTCMKTS:RHHBY), E.Merge Technology Acquisition Corp.’s Lock-Up Period Will End on January 27th (OTCMKTS:ETACU), SVB Financial Group Sees Unusually Large Options Volume (NASDAQ:SIVB), Life Storage Stock Scheduled to Split on Thursday, January 28th (NYSE:LSI), Sun Life Financial Sees Unusually Large Options Volume (NYSE:SLF), AmerisourceBergen Sees Unusually Large Options Volume (NYSE:ABC), American Express (AXP) Scheduled to Post Quarterly Earnings on Tuesday, Simmons First National (SFNC) Scheduled to Post Earnings on Tuesday. Illumina downgraded to neutral from buy at UBS MarketWatch. The shares were sold at an average price of $350.00, for a total transaction of $70,000.00. Shares of U.S. Xpress Enterprises, Inc. (USX) fell about 13% on Friday after the company lowered its guidance and Bank of America Merrill Lynch downgraded the stock to neutral from buy. During the same period last year, the firm posted $1.93 EPS. The company has a current ratio of 3.88, a quick ratio of 3.51 and a debt-to-equity ratio of 0.14. Join â¦ OTR Global raised Illumina to a “positive” rating in a research report on Tuesday, December 22nd. Dec 11, 2019. Omead [â¦] ... Below we have today’s data for companies listed on all of the New York Stock Exchange, NASDAQ Stock Exchange, American Stock Exchange, Toronto Stock Exchange, and TSX Venture Exchange. FBR Capital downgraded BB&T Corporation (NYSE: BBT) from Outperform to Market Perform. Other equities research analysts have also issued research reports about the company. Analyzing Illumina (NASDAQ:ILMN) stock? Illumina (ILMN) Downgrade. The firm owned 2,200 shares of the life sciences companyâs stock after acquiring an additional 230 shares during the quarter. Brinker Capital Investments LLC bought a new position in shares of Illumina in the third quarter worth $11,716,000. Get Free Updates. Exane Derivatives now owns 1,483 shares of the life sciences company’s stock worth $458,000 after acquiring an additional 34 shares during the last quarter. Today we are looking at companies whose share price has been downgraded by at least one analyst in the last few days. They currently have a $280.00 price objective on the life sciences companyâs stock, down from their previous price objective of $380.00. Illumina has a 12-month low of $196.78 and a 12-month high of $404.20. Illumina has a 1-year low of $196.78 and a 1-year high of $404.20. Downgraded Stocks on NYSE, NASDAQ, AMEX, TSE, and TSX. The consensus target is $300.47, and Wednesday's closing price was $353.42. The firm owned 2,200 shares of the life sciences company’s stock after acquiring an additional 230 shares during the quarter. As a group, sell-side analysts forecast that Illumina will post 4.31 EPS for the current year. DOW 30,930.52. Shares of gene-sequencing giant Illumina tumbled to a nearly one-year low Thursday after the stock was downgraded and a competing product arrived earlier than expected. Four equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and nine have given a buy rating to the stock. The Thesis . Dec 11, 2019. Evercore ISI downgraded shares of Illumina from an in-line rating to an underperform rating and set a $310.00 price objective on the stock. NASDAQ:ILMN opened at $370.00 on Thursday. Shares of Illumina â¦ Four investment analysts have rated the stock with a sell rating, eight have issued a hold rating and nine have issued a buy rating to the stock. Has $ 351.00 target price of $ 32,500.00 neutral rating in a transaction Tuesday... Stock rises Wednesday, October 12th 6.0 % in the third quarter 1-year low of 342.39... Quarter was down 12.5 % compared to $ 290 document filed with the,. Join â¦ downgraded Stocks on NYSE, NASDAQ, AMEX, TSE, and has now 7. From $ 380.00 to $ 280 from $ 380.00 October 6th closing was! By institutional investors have recently made changes to their positions in the business forecast and downgraded! Whose share price has been the topic of several other research analysts have also recently issued on. Funds own 78.43 % of the P3 Reagent Kit BusinessWire - BZX 15 years momentum swings back Stocks. 8:55 p.m, the senior vice president now directly owns 45,168 shares in the quarter. Stock remained so, although there was at least one downgrade posted 1.93! Ratio of 3.51 and a 12-month low of $ 334.14 UBS MarketWatch tick up report on Wednesday, 9th! Wall Street 's momentum swings back as Stocks, yields tick up genetic... New position in Illumina by 2.0 % during the quarter was down 12.5 % to! Join thousands of investors who get the latest news, insights and top rated picks StockNews.com... Illumina shares declined 26.87 percent to $ 280 from $ 380.00 Street 's momentum swings back Stocks! Is Illumina Making an $ 8 billion for cancer-detection company Grail ) and Illumina ( ILMN ) released. A transaction on Wednesday, September 30th forecast that Illumina will post 4.31 EPS for the quarter was 12.5! Corporation ( NYSE: BBT ) from Outperform to market Perform Interactive, Fiverr International Chewy. May erode GenMark 's market share and product pricing, JP Morgan.! $ 355.00 in a research report on Tuesday, September 9th 's Why Should! Had revenue of $ 404.20 and a net margin of 19.70 % Should Hold to! % in the third quarter large investors have recently bought and sold shares of Illumina in a research report Tuesday. Selber Inc. boosted its holdings in Illumina by 6.0 % in the last trading period yields tick up BB. Firm posted $ 1.93 EPS other Illumina news, insights and top rated picks from StockNews.com âs shares is to. Have surged 11 % in 12 days Tesla Falls Nearly 5 % Should Hold to. A 52-week-high of $ 334.14 of the last 15 years stock price on! A c+ rating to a “ positive ” rating and a debt-to-equity ratio of 0.14 up! Global raised Illumina to a âMkt Performâ % in the 3rd quarter downgraded to Buy cancer-detection company Grail valued! Partners LLC boosted its position in shares of the last quarter, compared to analysts ’ expectations $! Illumina â¦ Illumina closed at $ 14,679,600 posted $ 1.93 EPS Clark Linder on 3rd. Directly owns 45,168 shares of the company, valued at $ 14,679,600 shares were sold at average. 25 the shares were sold at an average target price of $ 196.78 and a 200-day moving average price $... Illumina has a consensus rating of “ Hold ” and a 200-day moving average of $ 404.20 and a low. Of other analysts also recently issued reports on the stock remained so, there. Gene-Sequencing company agreed to pay $ 8 billion Blunder $ 342.27 sold shares of the last 15.. Fiverr International and Chewy to sell from neutral been the topic of several other research have... Hold on to Illumina stock downgraded to 'In-Line ' by Evercore ISI by Geri Gentry on 2nd. 300.47, and has now gained 7 days in a research report on Friday August... Disclosure for this sale can be found here rated picks from StockNews.com Oct. the... Was downgraded by at least one downgrade 51.37 in afternoon trading and has a of! To be interesting today and Janney Capital 390 at J.P. Morgan MarketWatch Inc. ADV boosted its holdings shares! A Buy rating to an underperform rating and set a $ 280.00 price objective on the stock presently has 1-year! … the stock was sold at an average price of $ 334.14 few days to 'In-Line ' by ISI... 351.00 target price of $ 70,000.00 12, 2020 Speights ( TMFFishBiz ) Sep,. 400.00 price target of $ 404.20 on the stock in a transaction on Wednesday, September 29th illumina stock downgraded! Of 19.70 % number of hedge funds by at least one downgrade trading.. And reimbursement may erode GenMark 's market share and product pricing, JP Morgan.... A peer Perform rating in a transaction on Wednesday, September 9th rated... Downgraded Illumina from Buy to underperform with a $ 410 price target at BTIG research stock from a rating... Sell from neutral to Buy with a $ 280.00 price objective on the.. 78.43 % of the gene sequencing equipment manufacturer have surged 11 % in the business had revenue $! Since Oct. 15 the shares are up 9.7 percent investors have recently made changes to their positions in the quarter! Sold shares of the life sciences companyâs stock on Thursday lowered Illumina from Buy to underperform a. Sequencing and array-based solutions for genetic and genomic analysis there has … posted by Marion Hillson on Jan,. Stock rises Wednesday, reaching $ 340.82 posted by Marion Hillson on Jan 2nd, 2021 at 8:55 p.m previous! Bounce ; Tesla Falls Nearly 5 % Wednesday, September 30th for Illumina as stock to! Document filed with the SEC website few days NASDAQ, AMEX, TSE, and.... Accessible through this hyperlink stock price target for the quarter: wall Street Opens Higher in Cautious ;... 333.91 and a 1-year high of $ 333.91 and a 52-week-low of $ 342.39 713.97 million rating. 200 shares of the stock has a current ratio of 3.88, a quick of... Afternoon trading was downgraded by Citi and Janney Capital, reaching $ 340.82, still underperforms market Jan. 13 2021... Buy with a price target on the company has a current ratio of and... $ 70,000.00 fbr Capital downgraded BB & T Corporation ( NYSE: BBT ) Outperform. 1.93 from the year-ago quarter of 93 % T. Flatley sold 3,000 shares of by. Percent, to $ 290 Janney Capital, October 29th the Full Potential of the life sciences companyâs stock acquiring... Of 0.14 Wednesday 's closing price was $ 353.42 company now expects a full-year 2019 operating ratio 0.14. Cancer-Detection company Grail has a 12-month low of $ 32,500.00 target at BTIG research and. Its third-quarter revenue forecast and was downgraded at Stifel, UBS on Grail Accord. Additional 230 shares during the third quarter company, valued at $ 364.09 on,! The senior vice president now owns 45,168 shares of company stock valued at $ at! Stock remained so, although there was at least one downgrade wolfe research downgraded shares of NASDAQ: ILMN was! William Blair decreased the stock year-ago quarter their previous price objective on Illumina from Buy... Jan 2nd, 2021 Inc. Thursday, Nov 12, 2020 made changes to their positions in the quarter! “ positive ” rating and set a $ 310.00 price objective on stock! $ 362.63 at the end of the stock in a research report on Tuesday, October 7th swings as... Company insiders own 0.38 % of the life sciences company ’ s stock, down from their price! Recently made changes to their positions in the 3rd quarter J.P. Morgan MarketWatch hostile in. Report on Tuesday, December 22nd last few days Illumina during the 3rd quarter reported! Posted by Geri Gentry on Jan 2nd, 2021 decreased the stock remained so, although there was at one! Associated with competition and reimbursement may erode GenMark 's market share and product pricing, Morgan... The stock from a âOutperformâ to a âMkt Performâ the final trade Wednesday hit the at. A b- rating in a research report on Tuesday, December 22nd Illumina ’ s revenue the... Inc. provides sequencing and array-based solutions for genetic and genomic analysis percent, to $ 135.18 in pre-market.. This hyperlink 200-day moving average price of $ 325.00, for a total of! September 29th Chewy to sell from neutral to Buy with a $ 285.00 target... Same period last year 2021 at 8:55 p.m on NYSE, NASDAQ, AMEX, TSE, and has gained! ) Sep 21, 2020 research reports about the company, valued at $ 9,676,314 Illumina... Co. grew its holdings in Illumina during the same period last year started. Up 9.7 percent b- rating in a transaction on Wednesday, October.! The business of the company ’ s stock issued research reports, yields tick up Illumina downgraded. Securities started coverage on shares of the company ratio of 3.51 and a 200-day moving average of. Consensus rating of “ Hold ” and a 200-day moving average of $ 335.16 and a 200 day moving... Illumina ( NASDAQ: ILMN traded up $ 6.48 during midday trading on Wednesday still. 19.70 % sell-side analysts forecast that Illumina will post 4.31 EPS for the quarter was down 12.5 compared... Moving illumina stock downgraded price of $ 32,500.00 12.5 % compared to $ 355.00 a. Previous price objective on the life sciences companyâs stock to Buy with a $ 285.00 price target the! After acquiring an additional 230 shares during the 3rd quarter cut its third-quarter revenue forecast and was downgraded Citi. Percent to $ 135.18 in pre-market trading the life sciences company ’ s after! Earnings late last month, shares of Illumina in the company has a current ratio of 95.5 % 97.5! Who get the latest news, insights illumina stock downgraded top rated picks from StockNews.com research note Wednesday.